Herbas VPB

Print
EN | LT
Supplementary protection
LT - Laktamą turintys junginiai ir jų dariniai kaip XA faktoriaus inhibitoriai
EN - LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
SPC
(11) Number of the document C 1427415
(68) Number of the document 1427415
(21) Application number for Supplementary Protection Certificate PA 2011 012
(22) Date of filing the application 2011-09-29
(41) Date of publication of the application 2012-07-25
Date of publication of SPC 2013-03-25
(24) Date of coming into effect of SPC 2022-09-18
Applicant
(71) Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton NJ 08543-4000, US
Grantee
(73) Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16, 6312 Steinhausen, CH
Attorney or representative
(74) Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/11/691, 2011-05-18
Calculated date of expiry of the SPC
(94) 2026-05-20
Name of the product protected by the basic patent
(95) Apixabanum
Paediatric extension
Request filed SPC extension granted until Request refused
2023-09-04 2026-11-20
Last renewal fee
Payment date Validity (years) Amount
2025-08-25 4 347.00 EUR
Next renewal fee
2026-09-18
Legal status
SPC term extension granted
Last update date 2025-08-26